NTRA Q4 2019 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q4 2019 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$83M+24.3% YoY

Gross Profit

$39M46.6% margin

Operating Income

-$35M-41.8% margin

Net Income

-$35M-42.3% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+6.8%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$17M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$583M

Total Liabilities

$304M

Stockholders' Equity

$279M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$67M	+24.3%
Gross Profit	$39M	$24M	+60.4%
Operating Income	-$35M	-$30M	-17.1%
Net Income	-$35M	-$32M	-10.5%

Revenue Segments

Product

$74M86%

Licensing And Other

$9M10%

Other Licensing And Other

$4M4%

Geographic Segments

U

$73M92%

Other Geographic Areas

$5M7%

Americas Excluding Us

$827,0001%